Wednesday, July 29, 2020

Obsolete and Outdated- National Guidelines for Stem Cell Research - 2017 INDIA and stem cell therapies

NAC-SCRT, Government of India
Secretariat, ICMR Headquarters, Ansari Nagar, New Delhi-110029  Telefax: +91- 11 - 26589791  Email: nacscrt.pg@icmr.gov.in

National Apex Committee for Stem Cell Research and Therapy

Department of Health Research

Ministry of Health & Family Welfare

Government of India


© 2018 National Apex Committee for Stem Cell Research and Therapy. All Rights Reserved.

Designed & developed by NAC-SCRT. Hosted by BIC, ICMR.

HomeAbout NAC-SCRTIC-SCR RegistrationDownloadsFAQsExternal LinksNews & ViewsContact Us


All registered IC-SCRs must submit annual reports in the prescribed format

SPOTLIGHT

India Portal
“As per the National Guidelines for Stem Cell Research - 2017, at present, there are no approved indications for stem cell therapy other than Haematopoietic Stem Cell Transplantation (HSCT) for haematological disorders. Accordingly, all stem cell therapies other than the above shall be treated as investigational and may be conducted only in the form of clinical trials after obtaining necessary regulatory approvals. Use of stem cells for any other purpose outside the domain of clinical trials will be considered unethical and hence not permissible.”

No comments: